跳转到主要内容


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

新闻

Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards

Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards

We won the API Supplier of the Year Award for our strong commitment as a reliable API supplier to global formulating companies but also to take on the challenge of being part of the solution to address the pandemic. The nomination reflects on Dr. Reddy’s efforts to bring science, technology, and innovation together to provide a COVID-19 portfolio from prevention (SPUTNIK V) to cure (Remdesivir, Favipiravir, etc..).

At the same time, the team was able to respond to the increased demand for high-quality APIs, which resulted a two-digit growth and helped its partners ensure their medicines are available wherever and whenever needed.

To know more about our API Portfolio, write to us at: api@drreddys.com.

Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards

Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards

Contact Us

请填写以下表格,我们会尽快与您联系.

给我们发电子邮件: api@drreddys.com | +91 40 49002222

免责声明

本目錄中的任何信息(包括對任何產品或服務的任何引用)均不構成銷售要約,或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是,只要存在此類監管豁免,就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估,並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途,但可用於第 107A 節。

X
Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit